---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-147017"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:11:08.629374+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences prices $75M public offering of stock and warrants

## Summary
- Priced 5,630,450 shares at $12.00/share and 619,606 pre-funded warrants at $11.999/warrant.
- Gross proceeds expected ~$75M; net ~$70M (or ~$80.5M if underwriters' option exercised).
- Proceeds for working capital, general corporate purposes, funding clinical/preclinical development.
- Offering expected to close June 26, 2025, subject to customary closing conditions.
- Underwriters granted 30-day option to purchase up to 937,508 additional shares.

## SEC filing metadata
- accession: 0001193125-25-147017
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312525147017/0001193125-25-147017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312525147017/d944948d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-147017
- JSON: https://secwatch.observer/filing/0001193125-25-147017.json
- Plain text: https://secwatch.observer/filing/0001193125-25-147017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.